Pharmaceutical

Boehringer and CBmed partner to develop cancer therapies

Boehringer has entered a strategic collaboration with CBmed to expedite the translation of cancer treatment approaches into new therapies.

Feb 10, 2024 - 18:00
Boehringer and CBmed partner to develop cancer therapies
Boehringer has entered a strategic collaboration with CBmed to expedite the translation of cancer treatment approaches into new therapies.
Read the original article

Tags:

Previous Article

Janssen seeks EMA approval of RYBREVANT for NSCLC

Next Article

AstraZeneca posts 81% rise in FY 2023 profit after tax

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Neuvivo makes bid to enter ALS arena with immunotherapy candidate

Neuvivo makes bid to enter ALS arena with immunotherapy...

Oct 8, 2024

Mesoblast plans new GvHD trial after another FDA rejection

Mesoblast plans new GvHD trial after another FDA rejection

Aug 4, 2023

STAT+: How to ‘break the logjam’? Economists pitch a plan to curb dire drug shortages

STAT+: How to ‘break the logjam’? Economists pitch a pl...

Jul 12, 2023